Cardiovascular disease and cancer are the two leading causes of morbidity and mortality in
the world. The emerging field of cardio-oncology has revealed that these seemingly …

Cardiovascular diseases represent a major cause of morbidity and mortality, necessitating
research to improve diagnostics, and to discover and test novel preventive and curative …

Aims Cardiotoxicity leading to heart failure (HF) is a growing problem in many cancer
survivors. As specific treatment strategies are not available, RNA discovery pipelines were …

Background Immune checkpoint inhibitor-related cardiotoxicity is one of the most lethal
adverse effects, and thus, the identification of underlying mechanisms for developing …

Mitochondrial dysfunction is a crucial contributor to heart diseases. Alterations in energetic
metabolism affect crucial homeostatic processes, such asATP production, the generation of …

Innate immune cells are the early responders to infection and tissue damage. They play a
critical role in the initiation and resolution of inflammation in response to insult as well as …

Abstract Purpose of Review Immune checkpoint inhibitors, such as monoclonal antibodies
targeting CTLA-4, PD-1, and PD-L1, have improved the outcome of many malignancies, but …

Cardiovascular disease is the major cause of morbidity and mortality in breast cancer
survivors. Chemotherapy contributes to this risk. We aimed to define the mechanisms of long …

We present the hypothesis that advanced stage cancer is also a heart failure syndrome. It
can develop independently of or in addition to cardiotoxic effects of anti‐cancer therapies …

LncRNAs function as molecular sponges for miRNAs to control their availability for targeting
mRNA molecules. This procedure indirectly regulates the expression of cancer-related …